New advances in paediatric oncology

Host: Darren Hargrave, Great Ormond Street Hospital


Room: Room 2N

This session will provide an overview of recent advances in childhood cancer including talks on the progress and challenges in understanding the genomic drivers of childhood cancer. Translating these findings into targeted precision medicine for paediatric oncology and how immunotherapy approaches can be applied to childhood cancer. The session will provide an update for those working in the field of paediatric oncology but also an insight into the current and future management of childhood cancer for those who work mainly with adult cancers. The session will be suitable for clincians, nurses, translational scientists and interested patients and carers.

Confirmed speakers:
Stephen Gottschalk, Texas Children’s Hospital, Clinical Care Center (Clinic), USA
Marcel Kool, DKFZ, Germany
Sam Behjati, Wellcome Trust Sanger Institute, UK

Molecular classification of pediatric brain tumors identifies new brain tumor entities
Targeting MYC/MYCN by inhibition of checkpoint kinase 1 (CHK1) sensitises paediatric glioblastoma (pGBM) cells to temozolomide
Simulated low dose cone beam CT (CBCT) in paediatric patients
Engineering T cells for pediatric cancer immunotherapy